US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Levonorgestrel Non-Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. NDC 44132-012-01 D-0660-2017
Class II · Moderate risk Terminated

Ethinyl Estradiol Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. NDC 44132-002-05 D-0659-2017
Class II · Moderate risk Terminated

Testosterone Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. NDC 44132-006-06 D-0658-2017
Class II · Moderate risk Terminated

Estrone Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. NDC 44132-003-04 D-0657-2017
Class II · Moderate risk Terminated

Estriol Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. D-0656-2017
Class II · Moderate risk Terminated

Estradiol Non-Micronized

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. D-0655-2017
Class II · Moderate risk Terminated

Estradiol Micronized Bulk

Reason cGMP Deviations; lack of quality assurance.

Qinhuangdao Zizhu Pharmaceutical, Co. NDC 44132-001-01 D-0654-2017
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-208-20 D-0622-2017
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Mylan Pharmaceuticals Inc. NDC 0378-3953-09 D-0621-2017
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Mylan Pharmaceuticals Inc. NDC 0378-3952-09 D-0620-2017
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Mylan Pharmaceuticals Inc. NDC 0378-3951-09 D-0619-2017
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Mylan Pharmaceuticals Inc. NDC 0378-3950-77 D-0618-2017
Class II · Moderate risk Terminated

Latanoprost Ophthalmic Solution

Reason Lack of assurance of sterility: product was found to be empty, under-filled, or leaking.

Akorn, Inc. NDC 17478-625-12 D-0661-2017
Class II · Moderate risk Terminated

Kalbitor

Reason Presence of Particulate Matter: Glass

Shire NDC 47783-101-01 D-0625-2017
Class II · Moderate risk Terminated

Divalproex Sodium Delayed Release Tablets

Reason Failed Dissolution Specifications; 9 month long term stability

Zydus Pharmaceuticals USA Inc NDC 68382-033-01 D-0617-2017
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason Presence of Particulate Matter

Sun Pharmaceutical Industries, Inc. NDC 62756-015-40 D-0611-2017
Class II · Moderate risk Terminated

Cotellic

Reason Superpotent Drug: An oversized tablet was found in a bottle.

Genentech Inc. NDC 50242-717-01 D-0648-2017
Class II · Moderate risk Terminated

Metronidazole Injection

Reason Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Claris Lifesciences Inc NDC 36000-001-24 D-0616-2017
Class II · Moderate risk Terminated

Levofloxacin Injection in 5% Dextrose

Reason Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Claris Lifesciences Inc NDC 36000-048-24 D-0615-2017
Class II · Moderate risk Terminated

Fluconazole Injection

Reason Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Claris Lifesciences Inc NDC 36000-003-06 D-0614-2017
Class II · Moderate risk Terminated

Ciprofloxacin in Dextrose

Reason Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Claris Lifesciences Inc NDC 36000-009-24 D-0613-2017
Class II · Moderate risk Terminated

hydrALAZINE HYDROCHLORIDE INJECTION

Reason Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.

Mckesson Medical Surgical NDC 63323-614-01 D-0668-2017
Class II · Moderate risk Terminated

ATENOLOL Tablets

Reason Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Legacy Pharmaceutical Packaging LLC NDC 68645-493-54 D-0606-2017